Cohen IR - Search Results

1

Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.

Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z. Vlodavsky I, et al. Among authors: cohen ir. Invasion Metastasis. 1992;12(2):112-27. Invasion Metastasis. 1992. PMID: 1399400 Review.

2

Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity.

Lider O, Mekori YA, Miller T, Bar-Tana R, Vlodavsky I, Baharav E, Cohen IR, Naparstek Y. Lider O, et al. Among authors: cohen ir. Eur J Immunol. 1990 Mar;20(3):493-9. doi: 10.1002/eji.1830200306. Eur J Immunol. 1990. PMID: 2318247

3

Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.

Fridman R, Lider O, Naparstek Y, Fuks Z, Vlodavsky I, Cohen IR. Fridman R, et al. Among authors: cohen ir. J Cell Physiol. 1987 Jan;130(1):85-92. doi: 10.1002/jcp.1041300113. J Cell Physiol. 1987. PMID: 2433294

4

Heparan sulfate degradation in tumor cell invasion and angiogenesis.

Vlodavsky I, Eldor A, Bar-Ner M, Fridman R, Cohen IR, Klagsbrun M. Vlodavsky I, et al. Among authors: cohen ir. Adv Exp Med Biol. 1988;233:201-10. doi: 10.1007/978-1-4899-5037-6_22. Adv Exp Med Biol. 1988. PMID: 2464906 Review. No abstract available.

5

Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.

Lider O, Baharav E, Mekori YA, Miller T, Naparstek Y, Vlodavsky I, Cohen IR. Lider O, et al. Among authors: cohen ir. J Clin Invest. 1989 Mar;83(3):752-6. doi: 10.1172/JCI113953. J Clin Invest. 1989. PMID: 2493485 Free PMC article.

6

Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.

Bar-Ner M, Eldor A, Wasserman L, Matzner Y, Cohen IR, Fuks Z, Vlodavsky I. Bar-Ner M, et al. Among authors: cohen ir. Blood. 1987 Aug;70(2):551-7. Blood. 1987. PMID: 2955820 Free article.

7

Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase.

Naparstek Y, Cohen IR, Fuks Z, Vlodavsky I. Naparstek Y, et al. Among authors: cohen ir. Nature. 1984 Jul 19-25;310(5974):241-4. doi: 10.1038/310241a0. Nature. 1984. PMID: 6205275

8

A cellulose-binding domain-fused recombinant human T cell connective tissue-activating peptide-III manifests heparanase activity.

Rechter M, Lider O, Cahalon L, Baharav E, Dekel M, Seigel D, Vlodavsky I, Aingorn H, Cohen IR, Shoseyov O. Rechter M, et al. Among authors: cohen ir. Biochem Biophys Res Commun. 1999 Feb 24;255(3):657-62. doi: 10.1006/bbrc.1999.0181. Biochem Biophys Res Commun. 1999. PMID: 10049766

9

A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase.

Lider O, Cahalon L, Gilat D, Hershkoviz R, Siegel D, Margalit R, Shoseyov O, Cohen IR. Lider O, et al. Among authors: cohen ir. Proc Natl Acad Sci U S A. 1995 May 23;92(11):5037-41. doi: 10.1073/pnas.92.11.5037. Proc Natl Acad Sci U S A. 1995. PMID: 7761444 Free PMC article.

10

Absence of major histocompatibility complex restriction in the interaction between processed basic protein and Ia of two rat strains.

Friedman A, Lider O, Beraud E, Cohen IR. Friedman A, et al. Among authors: cohen ir. Scand J Immunol. 1989 Jun;29(6):747-50. Scand J Immunol. 1989. PMID: 2787050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

481 results

Search Page

Filters